Back to search
Sojourn Therapeutics Limited
16591284
active
Private Limited Company
Health Score
65 / 100
Some Concerns
25/30
Filing
0/30
Financial
40/40
Risk
No risk factors detected.
Details
167-169 GREAT PORTLAND STREET, LONDON, W1W 5PF
Incorporated 18/07/2025
Compliance
Accounts
Up to date
Confirmation statement
Up to date
Industry
72110
Research and experimental development on biotechnologyOfficers
Joseph John Wilson
secretary · Since 18/07/2025
Professor Tuomas Pertti Jonathan Knowles
director · Since 18/07/2025
DIRECTOR
BRITISH · ENGLAND · Age 47
Also on 3 other boards
Mr George Kelly Martin
director · Since 18/07/2025
DIRECTOR
AMERICAN · UNITED STATES · Age 67
Also on 3 other boards
Persons with Significant Control
Samuel Cohen
25–50% shares
25–50% votes
British · England · Age 39
167-169, Great Portland Street, London, W1W 5PF
Notified 18/07/2025
Professor Tuomas Pertti Jonathan Knowles
25–50% shares
25–50% votes
British · England · Age 47
167-169, Great Portland Street, London, W1W 5PF
Notified 18/07/2025
Mr George Kelly Martin
Significant control
American · United States · Age 67
523, Harbor Road, Southport, 06890
Notified 18/07/2025